Literature DB >> 24931831

Principles and engineering of antibody folding and assembly.

Matthias J Feige1, Johannes Buchner2.   

Abstract

Antibodies are uniquely suited to serve essential roles in the human immune defense as they combine several specific functions in one hetero-oligomeric protein. Their constant regions activate effector functions and their variable domains provide a stable framework that allows incorporation of highly diverse loop sequences. The combination of non-germline DNA recombination and mutation together with heavy and light chain assembly allows developing variable regions that specifically recognize essentially any antigen they may encounter. However, this diversity also requires tailor-made mechanisms to guarantee that folding and association of antibodies is carefully this diversity also requires tailor-made mechanisms to guarantee that folding and association of antibodies is carefully controlled before the protein is secreted from a plasma cell. Accordingly, the generic immunoglobulin fold β-barrel structure of antibody domains has been fine-tuned during evolution to fit the different requirements. Work over the past decades has identified important aspects of the folding and assembly of antibody domains and chains revealing domain specific variations of a general scheme. The most striking is the folding of an intrinsically disordered antibody domain in the context of its partner domain as the basis for antibody assembly and its control on the molecular level in the cell. These insights have not only allowed a better understanding of the antibody folding process but also provide a wealth of opportunities for rational optimization of antibody molecules. In this review, we summarize current concepts of antibody folding and assembly and discuss how they can be utilized to engineer antibodies with improved performance for different applications. This article is part of a Special Issue entitled: Recent advances in the molecular engineering of antibodies.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antibody assembly; Antibody engineering; Antibody folding

Year:  2014        PMID: 24931831     DOI: 10.1016/j.bbapap.2014.06.004

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  17 in total

1.  Quantitative Interactome Proteomics Reveals a Molecular Basis for ATF6-Dependent Regulation of a Destabilized Amyloidogenic Protein.

Authors:  Lars Plate; Bibiana Rius; Bianca Nguyen; Joseph C Genereux; Jeffery W Kelly; R Luke Wiseman
Journal:  Cell Chem Biol       Date:  2019-05-16       Impact factor: 8.116

2.  Alginate-Based Amphiphilic Block Copolymers as a Drug Codelivery Platform.

Authors:  Yunpeng Feng; Sean P Quinnell; Alison M Lanzi; Arturo J Vegas
Journal:  Nano Lett       Date:  2021-09-08       Impact factor: 12.262

3.  Energy landscapes of functional proteins are inherently risky.

Authors:  Anne Gershenson; Lila M Gierasch; Annalisa Pastore; Sheena E Radford
Journal:  Nat Chem Biol       Date:  2014-11       Impact factor: 15.040

4.  Biochemical nature of Russell Bodies.

Authors:  Maria Francesca Mossuto; Diletta Ami; Tiziana Anelli; Claudio Fagioli; Silvia Maria Doglia; Roberto Sitia
Journal:  Sci Rep       Date:  2015-07-30       Impact factor: 4.379

Review 5.  Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies.

Authors:  Christian H K Lehmann; Lukas Heger; Gordon F Heidkamp; Anna Baranska; Jennifer J Lühr; Alana Hoffmann; Diana Dudziak
Journal:  Vaccines (Basel)       Date:  2016-03-28

6.  Expression of antibody fragments in Saccharomyces cerevisiae strains evolved for enhanced protein secretion.

Authors:  Yanyan Wang; Xiaowei Li; Xin Chen; Jens Nielsen; Dina Petranovic; Verena Siewers
Journal:  Microb Cell Fact       Date:  2021-07-14       Impact factor: 5.328

7.  The reduced form of the antibody CH2 domain.

Authors:  Zhaoyong Xi; Xianglei Liu; Rui Lin; John D Persons; Tatiana V Ilina; Wei Li; Dimiter S Dimitrov; Rieko Ishima
Journal:  Protein Sci       Date:  2021-06-16       Impact factor: 6.993

8.  Systematic screening of soluble expression of antibody fragments in the cytoplasm of E. coli.

Authors:  Anna Gaciarz; Johanna Veijola; Yuko Uchida; Mirva J Saaranen; Chunguang Wang; Sohvi Hörkkö; Lloyd W Ruddock
Journal:  Microb Cell Fact       Date:  2016-01-25       Impact factor: 5.328

9.  Comparing domain interactions within antibody Fabs with kappa and lambda light chains.

Authors:  Raheleh Toughiri; Xiufeng Wu; Diana Ruiz; Flora Huang; John W Crissman; Mark Dickey; Karen Froning; Elaine M Conner; Thomas P Cujec; Stephen J Demarest
Journal:  MAbs       Date:  2016-07-25       Impact factor: 5.857

10.  Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening.

Authors:  Hok Seon Kim; Diana Ronai Dunshee; Angie Yee; Raymond K Tong; Ingrid Kim; Farzam Farahi; Jo-Anne Hongo; James A Ernst; Junichiro Sonoda; Christoph Spiess
Journal:  Protein Eng Des Sel       Date:  2017-09-01       Impact factor: 1.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.